{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:11025495",
      "entity_text" : "cholesterol",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:9803963",
      "entity_text" : "GW501516",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "An additional role for PPARdelta activation in the lipid effects of GFT505 cannot be excluded given that a 2-week treatment of moderately obese patients with a pure PPARdelta synthetic agonist, GW501516, led to similar effects on plasma triglyceride and HDL cholesterol.",
  "reading_complete" : "2020-07-28T12:01:24Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T11:54:55Z",
  "trigger" : "led",
  "evidence" : [ "GW501516, led to similar effects on plasma triglyceride and HDL cholesterol" ],
  "pmc_id" : "3161281",
  "score" : 0
}